43 results
Keyword Extavia Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Extavia
interferon beta-1b, Multiple Sclerosis
Date of authorisation: 20/05/2008, Revision: 25, Authorised, Last updated: 16/01/2023Extavia Demyelinating Autoimmune … Extavia … Pack size EU/1/08/454/008 Extavia 250 µg / ml Powder and … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,17-19 March 2008
CHMP, Last updated: 20/03/2008Extavia … -
List item
Human medicine European public assessment report (EPAR): Tysabri (updated)
natalizumab, Multiple Sclerosis
Date of authorisation: 27/06/2006, Revision: 41, Authorised, Last updated: 20/11/2023 -
List item
Human medicine European public assessment report (EPAR): Mavenclad
Cladribine, Multiple Sclerosis
Date of authorisation: 22/08/2017, Revision: 9, Authorised, Last updated: 19/10/2023 -
List item
Human medicine European public assessment report (EPAR): Betaferon (updated)
interferon beta-1b, Multiple Sclerosis
Date of authorisation: 30/11/1995, Revision: 36, Authorised, Last updated: 24/11/2023 -
List item
Human medicine European public assessment report (EPAR): Lemtrada
alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013,
, Revision: 22, Authorised, Last updated: 30/10/2023
-
List item
Human medicine European public assessment report (EPAR): Tecfidera
dimethyl fumarate, Multiple Sclerosis
Date of authorisation: 30/01/2014, Revision: 28, Authorised, Last updated: 20/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
PRAC recommendations on safety signals (updated)
Last updated: 20/11/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 February 2014
European Medicines Agency, London, UK, from 03/02/2014 to 06/02/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 September 2013
European Medicines Agency, London, UK, from 02/09/2013 to 05/09/2013, Last updated: 02/07/2012 -
List item
PRAC recommendations on safety signals: monthly overviews: Archive
Last updated: 30/05/2017 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 27/11/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2015
European Medicines Agency, London, UK, from 07/04/2015 to 10/04/2015, Last updated: 20/05/2015 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 March 2016
European Medicines Agency, London, UK, from 14/03/2016 to 17/03/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 1-4 December 2014
European Medicines Agency, London, UK, from 01/12/2014 to 04/12/2014, Last updated: 13/08/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2022
Written procedure, from 16/08/2022 to 19/08/2022, Last updated: 04/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 October 2020
Virtual meeting, from 26/10/2020 to 29/10/2020, Last updated: 08/01/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 September 2014
European Medicines Agency, London, UK, from 08/09/2014 to 11/09/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 July 2014
European Medicines Agency, London, UK, from 07/07/2014 to 10/07/2014, Last updated: 13/08/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 November 2020
Virtual meeting, from 09/11/2020 to 12/11/2020, Last updated: 07/01/2021 -
List item
PRAC: meeting archive 2012-2014
Last updated: 13/05/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 November 2015
European Medicines Agency, London, UK, from 03/11/2015 to 06/11/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 May 2015
European Medicines Agency, London, UK, from 04/05/2015 to 07/05/2015, Last updated: 13/03/2014